Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Ovarian Neoplasms 44Lung Neoplasms 29Neuroblastoma 24Small Cell Lung Carcinoma 21Carcinoma, Ovarian Epithelial 19Fallopian Tube Neoplasms 17Neoplasms 14Brain Neoplasms 14Uterine Cervical Neoplasms 11Leukemia, Myeloid, Acute 11Leukemia 11Retinoblastoma 10Glioma 9Recurrence 8Sarcoma 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma 7Central Nervous System Neoplasms 7Sarcoma, Ewing 6Neoplasm Metastasis 6Lymphoma, Follicular 6Unspecified Adult Solid Tumor, Protocol Specific 5Osteosarcoma 5Gliosarcoma 5Glioblastoma 5Endometrial Neoplasms 5Burkitt Lymphoma 5Blast Crisis 5Astrocytoma 5Wilms Tumor 4

Interventions

Etoposide 2toripalimab 1fluzoparib 1atezolizumab 1Topotecan 1Temozolomide 1Radiotherapy 1PM 01183 1Drug Therapy 1Chemoradiotherapy 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × SCLC, Extensive Stage × Topotecan × Clear all
NCT07141771 2025-08-26

An Umbrella Study of Recurrent, Extensive Stage Small Cell Lung Cancer Based on Molecular Typing

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 1/2 Not yet recruiting
100 enrolled
Thoracic

SCLC, Extensive Stage

Data powered by HemOnc (CC BY 4.0) Colophon âš¡